Li Chong, Yan Ru-Ping, Yuan Guo-Hong, Feng You-Gang, Wang Jian-Song, Gao Xiang, Huang Yan-Shan, Zhou Jin-Bao, Xie Shu-Sheng
Department of Immunology, Peking University Health Science Center, Beijing 100083, China.
Zhonghua Zhong Liu Za Zhi. 2006 Oct;28(10):733-6.
A mouse model of orthotopic bladder cancer simulating its human counterpart is of great importance in preclinical evaluation of new treatment modalities such as immunotxin therapy. The aim of the present study is to establish a novel nude mouse model with xenografted human bladder cancer.
Single cell suspension of an established human bladder transitional cell carcinoma (TCC) cell line BIU-87 was instilled into nude mouse bladders which were pretreated with mild acid washing. The tumor growth in mouse bladder was assessed weekly by magnetic resonance imaging (MRI). At intervals following implantation and MRI tumor detection, the animals were sacrificed for necropsy, histological examination and immunocytochemical studies.
The overall tumor establishment was 92.9% (52/56 mice) at 7 - 36 days, while in the subgroup of animals sacrificed at 12 - 13 days, 40 out of 42 animals (95.2%) developed TCC, the majority of which was superficial. The tumor stages were assessed by gross and histopathology. Histological examination confirmed the presence of grade II - III TCC. Immunocytochemistry confirmed that the tumor model maintained the biological and immunological features of BIU-87 cells. The changes seen on MRI images well correlated with the extent of tumor invasion identified by histology. Carcinoma in situ could be detected histologically at 7 - 9 days post-inoculation and progressed into papillary or invasive tumors thereafter.
The orthotopic BIU-87 TCC model in nude mice is highly reproducible and is ideal for preclinical studies on experimental intravesical therapies.
在新治疗方式(如免疫毒素疗法)的临床前评估中,模拟人类原位膀胱癌的小鼠模型具有重要意义。本研究的目的是建立一种新型的人膀胱癌异种移植裸鼠模型。
将已建立的人膀胱移行细胞癌(TCC)细胞系BIU - 87的单细胞悬液注入经轻度酸洗预处理的裸鼠膀胱。每周通过磁共振成像(MRI)评估小鼠膀胱内的肿瘤生长情况。在植入和MRI检测到肿瘤后,定期处死动物进行尸检、组织学检查和免疫细胞化学研究。
在7 - 36天,总体肿瘤形成率为92.9%(52/56只小鼠),而在12 - 13天处死的动物亚组中,42只动物中有40只(95.2%)发生了TCC,其中大多数为浅表性。通过大体和组织病理学评估肿瘤分期。组织学检查证实存在II - III级TCC。免疫细胞化学证实该肿瘤模型保持了BIU - 87细胞的生物学和免疫学特征。MRI图像上看到的变化与组织学确定的肿瘤浸润程度密切相关。接种后7 - 9天组织学上可检测到原位癌,此后进展为乳头状或浸润性肿瘤。
裸鼠原位BIU - 87 TCC模型具有高度可重复性,是实验性膀胱内治疗临床前研究的理想模型。